Načítá se...
Approval gap of pharmacogenomic biomarkers and in vitro companion diagnostics between the United States and Japan
WHAT IS KNOWN AND OBJECTIVES: In vitro companion diagnostic devices (CDx) provide information on pharmacogenomic biomarkers (PGBMs) to enable the safe and effective use of targeted agents for personalized therapy. These devices require specific regulations that strike a balance between scientific ev...
Uloženo v:
| Vydáno v: | J Clin Pharm Ther |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BlackWell Publishing Ltd
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4237189/ https://ncbi.nlm.nih.gov/pubmed/24405254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcpt.12129 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|